regeneron dna - Search News

Order byBest matchMost fresh

Regeneron to buy bankrupt DNA testing company 23andMe

Digest more

Top News

Overview

Impacts

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million.

· 19h · on MSN

Daily Voice on MSN · 4h

Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

· 1d · on MSN

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

Regeneron agrees to buy bankrupt 23andMe

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA da...

· 22h

· 1d

Struggling DNA testing firm 23andMe to be bought for $256m

· 23h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Hold...

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

MassDevice32m

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to close in Q3 2025

Lohud.com, Westchester County on MSN22h

Regeneron to acquire 23andMe DNA testing firm. How that could impact your genetic data

Regeneron announced a plan to acquire genetic testing firm 23andMe through bankruptcy court, including access to personal genetic data. What to know

1don MSN

Regeneron to rescue 23andMe from bankruptcy in $256 million deal — but who really owns your genetic data now and what happens to your DNA privacy?

Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and what happens to millions of users' sensitive information. Once worth $6 billion,

Stocktwits on MSN1d

Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Efforts

Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),